Standards for conducting psychological tests for driving under the influence of cannabinoids

• Autorzy: Odachowska-Rogalska Ewa , Ucińska Monika

Identyfikatory

DOI

10.5604/01.3001.0055.2871

• Języki publikacji: EN

Abstrakty

EN

For many years, driving under the influence of psychoactive substances other than alcohol, i.e. substances with a similar effect, usually marijuana derivatives, has been an issue in Poland. Driving under the influence of a psychoactive substance is forbidden and results for example in a mandatory psychological examination aiming to determine the absence or existence of psychological contraindications to driving a vehicle (Article 82, paragraph 1, item 4a of the Act on Vehicle Drivers). However, defining contraindications remains a significant challenge. These should encompass not only factors related to the motivation for driving under the influence of substances, but also elements involved in diagnosing potential addiction, as well as psychological aspects that may form the basis for preventing similar behaviour in the future. Meanwhile, there are no guidelines for psychological examination of this group of people, or clear indications of the impact of substance use on mental processes required for driving a vehicle. Individuals using so-called medical marijuana – prescribed, for instance, for analgesic purposes – are subject to the same treatment as those who consume marijuana derivatives recreationally. That contributes to a social problem with a real impact on the road safety aspects. The article discusses the impact of marijuana derivatives on drivers and summarizes standards (recommendations) for psychologists dealing with diagnosis and judgments in the field of transport psychology. The article can also be a source of knowledge for lawyers, policemen and expert witnesses in this area.

Słowa kluczowe

EN

road traffic; transport psychology; psychoactive substances; marijuana

• Wydawca: Szkoła Główna Służby Pożarniczej
• Czasopismo: Zeszyty Naukowe SGSP / Szkoła Główna Służby Pożarniczej
• Rocznik: 2025
• Tom: Nr 95 (tom 2)
• Strony: 137--154
• Opis fizyczny: Bibliogr. 50 poz., rys.

Twórcy

autor

Odachowska-Rogalska Ewa

• The Maria Grzegorzewska University, Warsaw, Poland

• https://orcid.org/0000-0002-6163-8353

autor

Ucińska Monika

• Motor Transport Institute

• https://orcid.org/0000-0002-0302-0889

Bibliografia

• [1] Announcement of the Marshal of the Sejm of the Republic of Poland of 10 July 2024 on the publication of the consolidated text of the Act on Drivers (Polish Journal of Laws/Dz.U. 2024, item 1210, consolidated text).
• [2] Announcement of the Minister of Health of 17 July 2023 on the publication of the consolidated text of the Regulation of the Minister of Health on re-education courses on alcohol and drug abuse prevention and detailed conditions and procedures for referring individuals for medical or
• psychological examinations in the field of transport psychology (Polish Journal of Laws/Dz.U. 2023, item 1629).
• [3] Announcement of the Minister of Health of 24 November 2021 on the publication of the consolidated text of the Regulation of the Minister of Health on psychological examinations of persons applying for driving licences, drivers and persons performing work as drivers (Polish Journal of Laws/Dz.U. 2022, item 165).
• [4] Announcement of the Marshal of the Sejm of the Republic of Poland of 26 September 2024 on the publication of the consolidated text of the Road Transport Act (Polish Journal of Laws/Dz.U.2024, item 1539).
• [5] Arkell, T.R., Vinckenbosch, F., Kevin, R.C., Theunissen, E.L., McGregor, I.S., Ramaekers, J.G., (2020). Effect of cannabidiol and Δ9-tetrahydrocannabinol on driving performance: a randomized clinical trial. Jama, no. 324(21), pp. 2177–2186. DOI: 10.1001/jama.2020.21218
• [6] Bołtryk, P., (2014). Kryminologiczne i prawne aspekty posiadania narkotyków w Polsce (na przykładzie pochodnych konopi innych niż włókniste). Doctoral dissertation. Białystok: University of Bialystok, Faculty of Law. (in Polish). https://repozytorium.uwb.edu.pl/jspui/bitstream/11320/2597/1/P.Bołtryk%20-%20rozprawa%20doktorska.pdf. [25/04/2025]
• [7] Brown, B., Adams, A.J., Haegerstrom-Portnoy, G., Jones R.T., Flom, M.C. et al., (1975). Effects of alcohol and marijuana on dynamic visual acuity: I. Threshold measurements. Percept. Psychophys., no. 18, pp. 441–446. https://doi.org/10.3758/BF03204118
• [8] Degenhardt, L., Hall, W., (2002). Cannabis and Psychosis. Current Psychiatry Reports, no. 4(3), pp. 191–196. DOI: 10.1007/s11920-002-0026-5
• [9] Di Ciano, P., Rajji, T.K., Hong, L., et al., (2024). Cannabis and driving in older adults. JAMA Netw Open. no. 7(1), e2352233. DOI: 10.1001/jamanetworkopen.2023.52233
• [10] Drabek, M., Andysz, A., (2011). Wpływ zażywania marihuany i amfetaminy (oraz jej pochodnych) na prowadzenie pojazdów na podstawie wyników badań symulatorowych. Medycyna Pracy, no. 62(5), pp. 551–563. (in Polish)
• [11] Drummer, O.H., Gerostamoulos, J., Batziris, H., Chu, M., Caplehorn, J., Robertson, M.D., Swann, P., (2004). The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. Accident Analysis & Prevention, no. 36(2), pp. 239–248. DOI: 10.1016/s0001- 4575(02)00153-7
• [12] Fischer, B., Jutras-Aswad, D., Hall, W., (2023). Outcomes associated with nonmedical cannabis legalization policy in Canada: taking stock at the 5-year mark. Canadian Medical Association Journal, no. 195(39), pp. 1351–1353. https://doi.org/10.1503/cmaj.230808
• [13] Hartman, R.L., Huestis, M.A., (2013). Cannabis effects on driving skills. Clinical chemistry, no. 59(3), pp. 478–492. doi: 10.1373/clinchem.2012.194381
• [14] Hartman, R.L., Brown, T.L., Milavetz, G., Spurgin, A., Gorelick, D.A., Gaffney, G.R., & Huestis, M.A., (2016). Effect of blood collection time on measured Δ9-tetrahydrocannabinol concentrations: implications for driving interpretation and drug policy. Clinical chemistry, 62(2), pp. 367–377.
• [15] Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R., Rice, K.C., (1992). Cannabinoid receptor localization in brain. Proc Natl Acad Sci, no. 87(5), pp. 1932–6. DOI: 10.1073/pnas.87.5.1932
• [16] Hollister, L.E., (1986). Health aspects of cannabis. Pharmacological Reviews, no. 38, pp. 1–20.
• [17] Huestegge, L., Kunert, H.J., Radach, R., (2010). Long-term effects of cannabis on eye movement control in reading. Psychopharmacology, no. 209, pp. 77–84. DOI: 10.1007/s00213-009-1769-z
• [18] Kalant, H., (2004). Adverse effects of cannabis on health: an update of the literature since 1996. Progress in Neuro-Psychopharmacology & Biological Psychiatry, no. 28, pp. 849–863. DOI: 10.1016/j.pnpbp.2004.05.027
• [19] Klimkiewicz, A., Jasińska, A., (2018). Zdrowotne następstwa rekreacyjnego używania kannabinoidów. Psychiatria, no. 15(2), pp. 88–92. (in Polish)
• [20] Kochanowski, M., (2018). Zastosowanie techniki chromatografii gazowej z detekcją mas w oznaczaniu tetrahydrokannabinoli dla potrzeb opiniowania sądowego. Doctoral dissertation. Kraków: Jagiellonian University, Faculty of Chemistry. (in Polish)
• [21] Komenda Główna Policji (2025, 2024, 2023, 2022, 2021, 2020, 2019, 2018). Wypadki drogowe w Polsce, Warsaw. (in Polish)
• [22] Krajewski, K., (2015). Legalizacja cannabis w stanach Colorado i Waszyngton w USA oraz w Urugwaju. Serwis Informacyjny Narkomania, no. 3(71), pp. 13–18. (in Polish)
• [23] Krajewski, K., (2022). Regulacje prawne dotyczące medycznych zastosowań kannabinoidów, In: A. Klimkiewicz (ed.) Konopie i medyczne zastosowanie kannabinoidów – praktyczne rekomendacje. Warsaw, pp. 293–307. (in Polish)
• [24] Krajewski, K.,(2016). Różnorodność rozwiązań w polityce narkotykowej w Europie i na świecie. Serwis Informacyjny Narkomania, no. 4(76), pp. 7–11. (in Polish)
• [25] Kucińska, A., (2015). Konsekwencje używania i nadużywania. Pediatria po Dyplomie, no. 19(1), pp. 31–35. (in Polish)
• [26] Kurzthaler, I., Hummer, M., Miller, C., Sperner-Unterweger, B., Günther, V., Wechdorn, H., Battista, H.J., Fleischhacker, W.W., (1999). Effect of cannabis use on cognitive functions and driving ability. J. Clin. Psychiatry, no. 60(6), pp. 395–9. DOI: 10.4088/jcp.v60n0609
• [27] Lorenzetti, V., Solowij, N., Yücel, M., (2016). The role of cannabinoids in neuroanatomic alterations in cannabis users. Biological Psychiatry, no. 79, pp. 17–31. DOI: 10.1016/j.biopsych.2015.11.013.
• [28] Lundqvist, T., Jönsson S., Warkentin S., (2001). Frontal lobe dysfunction in long-term cannabis users. Neurotoxicol. Teratol., no. 23, pp. 437–443. DOI: 10.1016/s0892-0362(01)00165-9
• [29] Łuczak, A., Zużewicz, K., (2006). Zmęczenie kierowców a bezpieczeństwo pracy. Bezpieczeństwo Pracy: nauka i praktyka, no. 4, pp. 20–23. (in Polish)
• [30] Łuczak, A., Tarnowski, A., (2013). Temperament i osobowość w diagnozie predyspozycji kierowców. Wyniki badań. Warsaw: Centralny Instytut Ochrony Pracy. (in Polish)
• [31] Mailleux, P., Vanderhaeghen, J.J., (1992). Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparativereceptor binding radioautography and in situ hybridization histochemistry. Neuroscience, no. 48, pp. 655–668.
• [32] Mikulskaya, E., Martin, F., (2015). Motion discrimination is impaired in cannabis users. Front. Hum. Neurosci., no. 9, pp. 2459–2469.
• [33] Mikulskaya, E., Martin, F.H., (2018). Contrast sensitivity and motion discrimination in cannabis users. Psychopharmacology, no. 235, pp. 2459–2469. DOI: 10.1007/s00213-018-4944-2
• [34] O’Connor, A.R., Tidbury, L.P., (2018). Stereopsis: Are we assessing it in enough depth?. Clinical and Experimental Optometry, no. 101(4), pp. 485–494. DOI: 10.1111/cxo.12655
• [35] Okulicz-Kozaryn, K., (2005). Sprawozdanie z realizacji projektu Pilotażowe wdrożenie i ewaluacja funkcjonowania testów przesiewowych w procesie interwencji wobec nastolatków używających przetworów konopi i innych narkotyków. Krajowe Biuro do Spraw Przeciwdziałania Narkomanii.
• [36] Ortiz-Peregrina, S., Ortiz, C., Casares-López, M., Jiménez, J.R., Anera, R.G., (2021). Effects of cannabis on visual function and self-perceived visual quality. Scientific Reports, no. 11, pp. 1655. DOI: 10.1038/s41598-021-81070-5
• [37] Raport Substancje Psychoaktywne w Ruchu Drogowym. Serwis Informacyjny UZALEŻNIENIA, (03/04/2024) no. 1 (105). https://siu.praesterno.pl/artykul/829 [26.06.2025]. (in Polish)
• [38] Ronen, A., Gershon, P., Drobiner, H., Rabinovich, A., Bar-Hamburger, R., Mechoulam, R., Cassuto, Y., Shinar, D., (2008). Effects of THC on driving performance, physiological state and subjective feelings relative to alcohol. Accident Analysis & Prevention, no. 40(3), pp. 926–934. DOI: 10.1016/j.aap.2007.10.011
• [39] Schwitzer, T., Schwan, R., Angioi-Duprez, K., Ingster-Moati, I., Lalanne, L., Giersch, A., Laprevote, V., (2015). The cannabinoid system and visual processing: A review on experimental findings and clinical presumptions. Eur. Neuropsychopharmacol., no. 25, pp. 100–112. DOI: 10.1016/j.euroneuro.2014.11.002
• [40] Simmons, S.M., Caird, J.K., Sterzer, F., Asbridge, M., (2022). The effects of cannabis and alcohol on driving performance and driver behaviour: a systematic review and meta-analysis. Addiction, no. 117(7), pp. 1843–1856. DOI: 10.1111/add.15770
• [41] Smiley, A.M., Moskowitz, H., Zeidman, K., (1981). Driving simulator studies of marijuana alone and in combination with alcohol. Proceedings of the 25th Conference on the American Association for Automotive Medicine, pp. 107–116.
• [42] Sowa, A., (2023). Zioło na całe zło. Polityka, no. 49, pp. 31–33. (in Polish)
• [43] Stein, A.C., (1983). A simulator study of the combined effects of alcohol and marijuana on driving behavior. Report submitted to the National Highway safety Traffic Administration under contract DOT-HS-806405. California: Systems Technology Inc.
• [44] Szukalski, B., (2012). Charakterystyka środków psychoaktywnych. In: Jabłoński, P., Bukowska, B., Czabała, J. C. (eds.), Uzależnienie od narkotyków. Podręcznik dla terapeutów. Łódź: Krajowe Biuro Przeciwdziałania Narkomanii. (in Polish)
• [45] Verstraete, E., Veldink, J.H., Mandl, R.C., van den Berg, L.H., van den Heuvel, M.P., (2011). Impaired structural motor connectome in amyotrophic lateral sclerosis. PloS one, vol. 6(9), e24239. DOI: 10.1371/journal.pone.0024239
• [46] Wachowiak, R., (2009). Aktualne możliwości diagnostyczno-interpretacyjne w opiniowaniu sądowo lekarskim wpływu wybranych związków psychoaktywnych na zdolność psychomotoryczną człowieka. Prokuratura Okręgowa w Zielonej Górze, https://www.zielona-gora.po.gov.pl/magazyn/upload/lektury_elektroniczne/zabezpieczenie-materialu-do-badan-zielona-gora4.pdf
• [47] World Health Organization, (2024). Alcohol, Drugs and Addictive Behaviours Unit, https://www. who.int/teams/mental-health-and-substance-use/alcohol-drugs-and-addictive-behaviours/ drugs-psychoactive/cannabis. [26.06.2025]
• [48] World Health Organization, (2025). WHO Expert Committee on Drug Dependence: forty-seventh report. https://iris.who.int/handle/10665/381007. [26.06.2025]
• [49] Yazulla, S., (2008). Endocannabinoids in the retina: From marijuana to neuroprotection. Prog. Retin. Eye Res., no. 27, pp. 501–526. DOI: 10.1016/j.preteyeres.2008.07.002
• [50] Yücel, M., Lubman, D.I., Solowij, N., Brewer, W.J., (2007). Understanding drug addiction: a neuropsychological perspective. Australian & New Zealand Journal of Psychiatry, no. 41, pp. 957–968. DOI: 10.1080/00048670701689444